Annual D&A
$1.66 M
+$218.00 K+15.17%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual depreciation & amortization is currently $1.66 million, with the most recent change of +$218.00 thousand (+15.17%) on 31 December 2023. During the last 3 years, it has risen by +$907.00 thousand (+121.26%). BCRX annual D&A is now -27.00% below its all-time high of $2.27 million, reached on 31 December 2010.BCRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$311.00 K
-$9000.00-2.81%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly depreciation & amortization is currently $311.00 thousand, with the most recent change of -$9000.00 (-2.81%) on 30 September 2024. Over the past year, it has dropped by -$109.00 thousand (-25.95%). BCRX quarterly D&A is now -73.42% below its all-time high of $1.17 million, reached on 31 December 2010.BCRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.36 M
-$109.00 K-7.42%
30 September 2024
Summary:
BioCryst Pharmaceuticals TTM depreciation & amortization is currently $1.36 million, with the most recent change of -$109.00 thousand (-7.42%) on 30 September 2024. Over the past year, it has dropped by -$268.00 thousand (-16.46%). BCRX TTM D&A is now -40.01% below its all-time high of $2.27 million, reached on 31 December 2010.BCRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.2% | -25.9% | -16.5% |
| 3 y3 years | +121.3% | +35.8% | +73.0% |
| 5 y5 years | +114.9% | +70.9% | +84.5% |
BCRX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +121.3% | -26.5% | +81.9% | -17.8% | +75.0% |
| 5 y | 5 years | at high | +128.6% | -26.5% | +86.2% | -17.8% | +92.1% |
| alltime | all time | -27.0% | +835.0% | -73.4% | +677.5% | -40.0% | +704.7% |
BioCryst Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $311.00 K(-2.8%) | $1.36 M(-7.4%) |
| June 2024 | - | $320.00 K(+4.6%) | $1.47 M(-5.6%) |
| Mar 2024 | - | $306.00 K(-27.7%) | $1.56 M(-6.0%) |
| Dec 2023 | $1.66 M(+15.2%) | $423.00 K(+0.7%) | $1.66 M(+1.7%) |
| Sept 2023 | - | $420.00 K(+3.2%) | $1.63 M(+1.9%) |
| June 2023 | - | $407.00 K(+0.5%) | $1.60 M(+4.7%) |
| Mar 2023 | - | $405.00 K(+2.3%) | $1.52 M(+6.1%) |
| Dec 2022 | $1.44 M(+84.9%) | $396.00 K(+1.8%) | $1.44 M(+18.6%) |
| Sept 2022 | - | $389.00 K(+16.1%) | $1.21 M(+15.2%) |
| June 2022 | - | $335.00 K(+5.7%) | $1.05 M(+14.8%) |
| Mar 2022 | - | $317.00 K(+85.4%) | $916.00 K(+17.9%) |
| Dec 2021 | $777.00 K(+3.9%) | $171.00 K(-25.3%) | $777.00 K(-1.1%) |
| Sept 2021 | - | $229.00 K(+15.1%) | $786.00 K(+8.6%) |
| June 2021 | - | $199.00 K(+11.8%) | $724.00 K(+2.3%) |
| Mar 2021 | - | $178.00 K(-1.1%) | $708.00 K(-5.3%) |
| Dec 2020 | $748.00 K(+3.3%) | $180.00 K(+7.8%) | $748.00 K(-0.7%) |
| Sept 2020 | - | $167.00 K(-8.7%) | $753.00 K(-2.0%) |
| June 2020 | - | $183.00 K(-16.1%) | $768.00 K(+0.3%) |
| Mar 2020 | - | $218.00 K(+17.8%) | $766.00 K(+5.8%) |
| Dec 2019 | $724.00 K(-6.0%) | $185.00 K(+1.6%) | $724.00 K(-1.8%) |
| Sept 2019 | - | $182.00 K(+0.6%) | $737.00 K(-1.7%) |
| June 2019 | - | $181.00 K(+2.8%) | $750.00 K(-1.3%) |
| Mar 2019 | - | $176.00 K(-11.1%) | $760.00 K(-1.3%) |
| Dec 2018 | $770.00 K(+9.4%) | $198.00 K(+1.5%) | $770.00 K(+2.1%) |
| Sept 2018 | - | $195.00 K(+2.1%) | $754.00 K(+2.3%) |
| June 2018 | - | $191.00 K(+2.7%) | $737.00 K(+2.6%) |
| Mar 2018 | - | $186.00 K(+2.2%) | $718.00 K(+2.0%) |
| Dec 2017 | $704.00 K(+45.8%) | $182.00 K(+2.2%) | $704.00 K(+1.4%) |
| Sept 2017 | - | $178.00 K(+3.5%) | $694.00 K(+0.4%) |
| June 2017 | - | $172.00 K(0.0%) | $691.00 K(+13.7%) |
| Mar 2017 | - | $172.00 K(0.0%) | $608.00 K(+25.9%) |
| Dec 2016 | $483.00 K(+168.3%) | $172.00 K(-1.7%) | $483.00 K(+36.4%) |
| Sept 2016 | - | $175.00 K(+96.6%) | $354.00 K(+59.5%) |
| June 2016 | - | $89.00 K(+89.4%) | $222.00 K(+22.0%) |
| Mar 2016 | - | $47.00 K(+9.3%) | $182.00 K(+1.1%) |
| Dec 2015 | $180.00 K(+1.7%) | $43.00 K(0.0%) | $180.00 K(+1.7%) |
| Sept 2015 | - | $43.00 K(-12.2%) | $177.00 K(+1.7%) |
| June 2015 | - | $49.00 K(+8.9%) | $174.00 K(+3.0%) |
| Mar 2015 | - | $45.00 K(+12.5%) | $169.00 K(-4.5%) |
| Dec 2014 | $177.00 K(-41.8%) | $40.00 K(0.0%) | $177.00 K(-8.8%) |
| Sept 2014 | - | $40.00 K(-9.1%) | $194.00 K(-11.0%) |
| June 2014 | - | $44.00 K(-17.0%) | $218.00 K(-16.2%) |
| Mar 2014 | - | $53.00 K(-7.0%) | $260.00 K(-14.5%) |
| Dec 2013 | $304.00 K(-51.6%) | $57.00 K(-10.9%) | $304.00 K(-26.6%) |
| Sept 2013 | - | $64.00 K(-25.6%) | $414.00 K(-14.8%) |
| June 2013 | - | $86.00 K(-11.3%) | $486.00 K(-12.7%) |
| Mar 2013 | - | $97.00 K(-41.9%) | $557.00 K(-11.3%) |
| Dec 2012 | $628.00 K(-29.1%) | $167.00 K(+22.8%) | $628.00 K(-12.4%) |
| Sept 2012 | - | $136.00 K(-13.4%) | $717.00 K(-6.4%) |
| June 2012 | - | $157.00 K(-6.5%) | $766.00 K(-7.6%) |
| Mar 2012 | - | $168.00 K(-34.4%) | $829.00 K(-6.4%) |
| Dec 2011 | $886.00 K(-60.9%) | $256.00 K(+38.4%) | $886.00 K(-50.8%) |
| Sept 2011 | - | $185.00 K(-15.9%) | $1.80 M(-6.4%) |
| June 2011 | - | $220.00 K(-2.2%) | $1.92 M(-8.5%) |
| Mar 2011 | - | $225.00 K(-80.8%) | $2.10 M(-7.3%) |
| Dec 2010 | $2.27 M(+40.6%) | $1.17 M(+279.9%) | $2.27 M(+51.9%) |
| Sept 2010 | - | $308.00 K(-22.6%) | $1.49 M(-5.4%) |
| June 2010 | - | $398.00 K(+1.8%) | $1.58 M(-21.2%) |
| Mar 2010 | - | $391.00 K(-1.1%) | $2.00 M(+24.2%) |
| Dec 2009 | $1.61 M | $395.50 K(+0.4%) | $1.61 M(-4.0%) |
| Sept 2009 | - | $394.00 K(-52.1%) | $1.68 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $823.00 K(+77.8%) | $1.69 M(+4.1%) |
| Dec 2008 | $1.63 M(+18.7%) | $462.90 K(+13.7%) | $1.63 M(-8.7%) |
| Sept 2008 | - | $407.00 K(+6.0%) | $1.78 M(+7.9%) |
| June 2008 | - | $384.00 K(+3.2%) | $1.65 M(+9.3%) |
| Mar 2008 | - | $372.00 K(-39.8%) | $1.51 M(+10.3%) |
| Dec 2007 | $1.37 M(+69.0%) | $617.70 K(+123.0%) | $1.37 M(+41.3%) |
| Sept 2007 | - | $277.00 K(+13.5%) | $969.30 K(+12.5%) |
| June 2007 | - | $244.00 K(+5.6%) | $861.30 K(+3.0%) |
| Mar 2007 | - | $231.00 K(+6.3%) | $836.30 K(+3.2%) |
| Dec 2006 | $810.30 K(-6.3%) | $217.30 K(+28.6%) | $810.30 K(+1.2%) |
| Sept 2006 | - | $169.00 K(-22.8%) | $800.60 K(-5.5%) |
| June 2006 | - | $219.00 K(+6.8%) | $847.60 K(+0.2%) |
| Mar 2006 | - | $205.00 K(-1.3%) | $845.60 K(-2.2%) |
| Dec 2005 | $864.60 K(-9.8%) | $207.60 K(-3.9%) | $864.60 K(-2.8%) |
| Sept 2005 | - | $216.00 K(-0.5%) | $889.50 K(-2.5%) |
| June 2005 | - | $217.00 K(-3.1%) | $912.50 K(-2.8%) |
| Mar 2005 | - | $224.00 K(-3.7%) | $938.50 K(-2.1%) |
| Dec 2004 | $958.50 K(-13.0%) | $232.50 K(-2.7%) | $958.50 K(-1.6%) |
| Sept 2004 | - | $239.00 K(-1.6%) | $974.50 K(-1.6%) |
| June 2004 | - | $243.00 K(-0.4%) | $990.50 K(-4.9%) |
| Mar 2004 | - | $244.00 K(-1.8%) | $1.04 M(-5.4%) |
| Dec 2003 | $1.10 M(-11.6%) | $248.50 K(-2.5%) | $1.10 M(-5.0%) |
| Sept 2003 | - | $255.00 K(-13.3%) | $1.16 M(-4.5%) |
| June 2003 | - | $294.00 K(-3.3%) | $1.21 M(-3.9%) |
| Mar 2003 | - | $304.00 K(-0.8%) | $1.26 M(+1.4%) |
| Dec 2002 | $1.25 M(+18.8%) | $306.60 K(-1.1%) | $1.25 M(+0.6%) |
| Sept 2002 | - | $310.00 K(-9.6%) | $1.24 M(+3.8%) |
| June 2002 | - | $343.00 K(+19.5%) | $1.19 M(+8.4%) |
| Mar 2002 | - | $287.00 K(-4.1%) | $1.10 M(+5.0%) |
| Dec 2001 | $1.05 M(+56.8%) | $299.40 K(+13.0%) | $1.05 M(+15.2%) |
| Sept 2001 | - | $265.00 K(+6.0%) | $911.20 K(+9.8%) |
| June 2001 | - | $250.00 K(+6.4%) | $830.20 K(+10.8%) |
| Mar 2001 | - | $235.00 K(+45.8%) | $749.20 K(+12.0%) |
| Dec 2000 | $669.20 K(+33.8%) | $161.20 K(-12.4%) | $669.20 K(+10.1%) |
| Sept 2000 | - | $184.00 K(+8.9%) | $608.00 K(+16.0%) |
| June 2000 | - | $169.00 K(+9.0%) | $524.00 K(-5.6%) |
| Mar 2000 | - | $155.00 K(+55.0%) | $555.00 K(+11.0%) |
| Dec 1999 | $500.00 K(0.0%) | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Sept 1999 | - | $100.00 K(-50.0%) | $500.00 K(0.0%) |
| June 1999 | - | $200.00 K(+100.0%) | $500.00 K(0.0%) |
| Mar 1999 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Dec 1998 | $500.00 K(-16.7%) | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Sept 1998 | - | $100.00 K(-50.0%) | $500.00 K(-16.7%) |
| June 1998 | - | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $600.00 K(0.0%) |
| Dec 1997 | $600.00 K(+20.0%) | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Sept 1997 | - | $200.00 K(0.0%) | $600.00 K(+20.0%) |
| June 1997 | - | $200.00 K(+100.0%) | $500.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Dec 1996 | $500.00 K(-16.7%) | $100.00 K(0.0%) | $500.00 K(-16.7%) |
| Sept 1996 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| June 1996 | - | $200.00 K(+100.0%) | $600.00 K(+20.0%) |
| Mar 1996 | - | $100.00 K(-50.0%) | $500.00 K(-16.7%) |
| Dec 1995 | $600.00 K(0.0%) | $200.00 K(+100.0%) | $600.00 K(+20.0%) |
| Sept 1995 | - | $100.00 K(0.0%) | $500.00 K(-16.7%) |
| June 1995 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Mar 1995 | - | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| Dec 1994 | $600.00 K | $100.00 K(-50.0%) | $600.00 K(+20.0%) |
| Sept 1994 | - | $200.00 K(+100.0%) | $500.00 K(+66.7%) |
| June 1994 | - | $100.00 K(-50.0%) | $300.00 K(+50.0%) |
| Mar 1994 | - | $200.00 K | $200.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual D&A year-on-year change?
- What is BioCryst Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly D&A year-on-year change?
- What is BioCryst Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM D&A year-on-year change?
What is BioCryst Pharmaceuticals annual depreciation & amortization?
The current annual D&A of BCRX is $1.66 M
What is the all time high annual D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual depreciation & amortization is $2.27 M
What is BioCryst Pharmaceuticals annual D&A year-on-year change?
Over the past year, BCRX annual depreciation & amortization has changed by +$218.00 K (+15.17%)
What is BioCryst Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of BCRX is $311.00 K
What is the all time high quarterly D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly depreciation & amortization is $1.17 M
What is BioCryst Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, BCRX quarterly depreciation & amortization has changed by -$109.00 K (-25.95%)
What is BioCryst Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of BCRX is $1.36 M
What is the all time high TTM D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM depreciation & amortization is $2.27 M
What is BioCryst Pharmaceuticals TTM D&A year-on-year change?
Over the past year, BCRX TTM depreciation & amortization has changed by -$268.00 K (-16.46%)